Fujifilm's virus-detection kit adds to kits that can detect strains of the virus used by public health authorities as early-warning systems for infection trends. Picture: Wikimedia
Fujifilm's virus-detection kit adds to kits that can detect strains of the virus used by public health authorities as early-warning systems for infection trends. Picture: Wikimedia

Tokyo — A unit of Japan’s Fujifilm says it can develop detection kits for new variants of the coronavirus in about a month, to concerns over the spread of more infectious strains of the virus.

Fujifilm Wako Pure Chemical developed a kit that can identify the L452R variant, first identified in India and California and recently discovered in Tokyo. That adds to kits that can detect two other strains of the virus used by public health authorities as early-warning systems for infection trends.

“It’s very important to control the mutant strains in the early stages of their spread,” Kuniaki Okamoto, GM of the company’s life sciences operations, said.

Much of Japan is under a state of emergency as a fourth wave of Covid-19 assails the country with about two months to go until the planned opening of the Tokyo Olympics.

Western Japan has been hard hit from a more-infectious strain first found in Britain, while Tokyo governor Yuriko Koike sounded the alarm last week about the discovery of the Indian variant in the capital.

Fujifilm Wako’s kit uses reagent chemicals to detect mutations in the SARS-CoV-2 virus and can deliver results in about 100 minutes. The company is focusing on the Japanese market and will look to export the kits depending on demand and regulatory requirements in other countries, Okamoto said.

Known mainly for its camera and office solutions businesses, Fujifilm’s push into health care has become all the more apparent amid the pandemic. In addition to developing testing kits, the company is carrying out trials of its antiviral drug Avigan as a Covid-19 treatment.

The company has also invested heavily in Europe and the US to expand factories involved in making ingredients for vaccines and drugs.

Reuters

subscribe

Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.